Long-term Effects of COVID-19 in Athletes

COVID-19, although commonly associated with complications to the respiratory system, is increasingly understood to exert a significant impact on the heart and cardiovascular system. Cardiac abnormality including myocarditis has been shown in a large proportion of patients hospitalized for COVID-19.

Given that myocarditis is associated with sudden mortality in athletes, attention has turned to the risk of myocarditis following COVID-19 in athletic and highly active people. Researchers are seeking to establish the effectiveness of cardiac evaluation in stratifying athletes post-COVID-19 infection for fitness to return to training.

athleteImage Credit: sportpoint / Shutterstock.com

COVID-19 and cardiac complications

The coronavirus disease 2019 (COVID-19) pandemic is a current global disease outbreak caused by a virus belonging to the Coronaviridae family of viruses. As of January 2021, more than 95 million cases have been confirmed globally, with more than two million deaths attributed to COVID-19.

In earlier stages of the pandemic, much attention was focused on acute respiratory complications which increase the risk of mortality and morbidity. However, attention is now turning towards the impact that COVID-19 exerts on the cardiovascular system.

A small, but growing body of research suggests that the disease may exacerbate heart failure in patients with established cardiac conditions. Patients with acute COVID-19 have demonstrated elevated levels of troponin, a protein that is released when the heart muscle becomes damaged, in the bloodstream.

Myocarditis and COVID-19

Myocarditis simply refers to an inflammation of myocardium, or heart muscle. In many cases, myocarditis does not cause symptoms, meaning accurate prevalence in the population is difficult to calculate. When symptoms do occur, it causes fatigue, breathlessness, and arrhythmia. In acute cases, it may lead to heart failure or sudden death.

Myocarditis is usually caused by a viral infection, such as SARS-CoV-2. Coronaviruses are known to bind to angiotensin-converting enzyme (ACE-2), an enzyme that helps modulate a protein known as ANG II, which is implicated in blood pressure and inflammation. When the virus binds to ACE-2, its function is inhibited, and more ANG II is available to damage tissue.

Myocarditis can also occur following the ‘cytokine storm syndrome’ observed in some severe cases of COVID-19. In this condition, the production of cytokines that signal an immune response becomes accelerated, leading to widespread systemic inflammation. The incidence of myocarditis following severe COVID-19 infection is striking. Estimates suggest 60-80% of those discharged following hospitalization for COVID-19 show ongoing myocarditis.

myocarditisImage Credit: Artemida-psy / Shutterstock.com

Myocarditis and athletes

Given that myocarditis is a leading cause of sudden cardiac death among athletes, concerns over the risk of COVID-19 myocarditis in athletes have led to calls to evaluate athletes recovering from COVID-19 for myocarditis using magnetic resonance imaging (MRI) techniques.

One recent case series took MRI scans of 26 collegiate athletes who had tested positive for COVID-19, 12 of whom displayed mild symptoms and 14 of whom were asymptomatic. None of the participants had required hospitalization for their COVID-19 symptoms. Of the participants, cardiac MRI identified myocarditis was identified in 15% of the sample with a further 31% showing fibrosis of the cardiac tissue.

Although the authors could not draw any conclusions about the long-term consequences of myocarditis in athletes, they suggested that cardiac MRI could offer a useful tool post-SARS-CoV-2 infection to identify high-risk athletes from those safe to resume training and competition.

Following the publication of this study, the American College of Cardiology issued guidance for return-to-play for athletes and highly active people. It suggested that those with mild to moderate symptoms after a positive COVID-19 test should only resume training after complete symptom cessation and thorough cardiac biomarker and MRI evaluation.

However, a subsequent study published in January 2021 evaluated a larger cohort of athletes who had tested positive for COVID-19, using cardiac MRI, EEG, and serum markers of cardiac pathology. 145 competitive athletes with either mild to moderate or no symptoms were assessed approximately 15 days post-positive test result. Only two had MRI findings consistent with myocarditis, leading the authors to conclude that its incidence following COVID-19 was much less prevalent than previously thought.

Researchers from Vanderbilt University Medical Center (VUMC) in a soon-to-be-published study found a similar prevalence. The team compared COVID-19-positive athletes to healthy controls and healthy athletes and found only 3% of those who had tested positive had myocarditis.

However, none of the other screening tests they completed (including serum biomarkers, EKG and EEG) revealed any abnormalities, ruling out the possibility of using these simpler and more traditional screening methods. The authors concluded that cardiac MRI following COVID-19 is a useful tool for assessing athlete fitness prior to a return to sport.


  • Maron, B. J., Haas, T. S., Ahluwalia, A., Murphy, C. J., & Garberich, R. F. (2016). Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry. The American journal of medicine, 129(11), 1170–1177. https://doi.org/10.1016/j.amjmed.2016.02.031
  • Phelan D, Kim JH, Chung EH. A Game Plan for the Resumption of Sport and Exercise After Coronavirus Disease 2019 (COVID-19) Infection. JAMA Cardiol. 2020;5(10):1085–1086. doi:10.1001/jamacardio.2020.2136
  • Puntmann, V. O., Carerj, M. L., Wieters, I., Fahim, M., Arendt, C., Hoffmann, J., Shchendrygina, A., Escher, F., Vasa-Nicotera, M., Zeiher, A. M., Vehreschild, M., & Nagel, E. (2020). Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA cardiology, 5(11), 1265–1273. https://doi.org/10.1001/jamacardio.2020.3557
  • Rajpal, S., Tong, M. S., Borchers, J., Zareba, K. M., Obarski, T. P., Simonetti, O. P., & Daniels, C. J. (2021). Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA cardiology, 6(1), 116–118. https://doi.org/10.1001/jamacardio.2020.4916
  • Zheng, YY., Ma, YT., Zhang, JY. et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol 17, 259–260 (2020). https://doi.org/10.1038/s41569-020-0360-5

Further Reading

Last Updated: Feb 2, 2021

Clare Knight

Written by

Clare Knight

Since graduating from the University of Cardiff, Wales with first-class honors in Applied Psychology (BSc) in 2004, Clare has gained more than 15 years of experience in conducting and disseminating social justice and applied healthcare research.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Knight, Clare. (2021, February 02). Long-term Effects of COVID-19 in Athletes. News-Medical. Retrieved on July 24, 2024 from https://www.news-medical.net/health/Long-term-Effects-of-COVID-19-in-Athletes.aspx.

  • MLA

    Knight, Clare. "Long-term Effects of COVID-19 in Athletes". News-Medical. 24 July 2024. <https://www.news-medical.net/health/Long-term-Effects-of-COVID-19-in-Athletes.aspx>.

  • Chicago

    Knight, Clare. "Long-term Effects of COVID-19 in Athletes". News-Medical. https://www.news-medical.net/health/Long-term-Effects-of-COVID-19-in-Athletes.aspx. (accessed July 24, 2024).

  • Harvard

    Knight, Clare. 2021. Long-term Effects of COVID-19 in Athletes. News-Medical, viewed 24 July 2024, https://www.news-medical.net/health/Long-term-Effects-of-COVID-19-in-Athletes.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How does SARS-CoV-2 cause lymphopenia when T cells barely express ACE-2 receptors?